Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker

Liu, WW; Liu, CQ; You, J; Chen, ZL; Qian, C; Lin, WD; Yu, LA; Ye, LL; Zhao, L; Zhou, R

Zhao, L; Zhou, R (通讯作者),Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China.;Zhao, L; Zhou, R (通讯作者),Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangdong Prov Key Lab Mol Tumor Pathol, Guangzhou, Peoples R China.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022; 10 ():

Abstract

Background: N-6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT......

Full Text Link